Calypxo Hp

CALYPXO HP (methyl salicylate/menthol)

More Frequent & Less Frequent(results - 2) (results - 4)
Rare / Very Rare(results 13)

CALYPXO HP (methyl salicylate/menthol)

More Frequent

Severe

None

Less Severe

Stinging of skin

Less Frequent

Severe

None

Less Severe

Dry skin
Skin irritation
Stinging of skin

Rare / Very Rare

Severe

Anaphylaxis

Burns

Dyspnea

Facial edema

Hypersensitivity drug reaction

Periorbital edema

Pharyngeal edema

Skin ulcer

Superficial skin ulcer

Syncope

Throat constriction

Urticaria

Less Severe

Pruritus of skin

Contraindicated

None

Severe Precaution

None

Management or Monitoring Precaution

Salicylates (Topical)

Prolonged use or use on extensive skin areas may lead to systemic toxicity, e.g. hemostatic or metabolic changes.

1 Day – 13 Years
Prolonged use or use on extensive skin areas may lead to systemic toxicity, e.g. hemostatic or metabolic changes.

Methyl Salicylate (topical)

Severity Level:
2
Additional Notes: Small amount of drug absorbed systemically; not recomm in preg

Contraindicated

None

General	Excretion Potential	Effect on Infant	Notes
			None

Precaution Exists

Methyl Salicylate (topical/nasal)

Small amt of drug absorbed systemically;Risk of reye's syn w/oral salicylates

General	Excretion Potential	Effect on Infant	Notes
Evaluate use carefully	Unknown	Not known; no or inclusive data	Small amt of drug absorbed systemically;Risk of reye's syn w/oral salicylates

No Known Risk

None

General	Excretion Potential	Effect on Infant	Notes
			None

Contraindicated

None

Precaution Exists

None

No Known Risk

None